Literature DB >> 7202512

Contribution by purines to the neurogenic response of the vas deferens of the guinea pig.

J S Fedan, G K Hogaboom, J P O'Donnell, J Colby, D P Westfall.   

Abstract

The specific purine-receptor antagonist, arylazido aminopropionyl ATP (ANAPP3), was used to determine if purines released from nerves of the guinea-pig was deferens contribute to the neurogenic response. ANAPP3, which is a photoaffinity label, antagonized contractile responses of the in vitro vas deferens to transmural stimulation, reversibly in the presence of the compound and irreversibly after its photoactivation in the presence of the tissues. The antagonism by ANAPP3 was augmented by depletion of norepinephrine produced by reserpine pretreatment. Responses of untreated tissues were only slightly antagonized by the alpha-adrenoceptor blocker prazosin. However, neurogenic responses were markedly reduced in the combined presence of ANAPP3 and prazosin. ANAPP3 did not affect the release of tritium from tissues prelabeled with [3H]norepinephrine. The initial phasic component of the neurogenic response was preferentially antagonized by ANAPP3 whereas the secondary more tonic component of the response was preferentially antagonized by prazosin and reserpine pretreatment. Small, residual responses remaining after chemical sympathectomy produced by 6-hydroxydopamine pretreatment were potentiated, rather than inhibited, by ANAPP3 and were, unlike untreated tissues, sensitive to atropine. These and previous findings indicate that ATP or a related purine, originating from adrenergic neurons, acts as a co-transmitter with norepinephrine in this tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7202512     DOI: 10.1016/0014-2999(81)90600-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  54 in total

1.  Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.

Authors:  M Guitart; J Giraldo; E Goñalons; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.

Authors:  L D Todorov; S Mihaylova-Todorova; G L Craviso; R A Bjur; D P Westfall
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

Review 3.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

4.  Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery.

Authors:  I von Kügelgen; K Starke
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

5.  Comparison between sympathetic adrenergic and purinergic transmission in the dog mesenteric artery.

Authors:  I Muramatsu; T Ohmura; M Oshita
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

6.  Direct evidence against a role of ATP as the nonadrenergic, noncholinergic inhibitory neurotransmitter in guinea pig tenia coli.

Authors:  D P Westfall; G K Hogaboom; J Colby; J P O'Donnell; J S Fedan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Neurally evoked potentiation of tonic contractions in the guinea-pig vas deferens involves adenosine receptors.

Authors:  A Tsunoo; M Kurokawa; K Takahashi
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

8.  5-hydroxytryptamine releases adenosine 5'-triphosphate from nerve varicosities isolated from the myenteric plexus of guinea-pig ileum.

Authors:  M Al-Humayyd; T D White
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

9.  Absence of P2-purinoceptors in hippocampal pathways.

Authors:  T W Stone; N J Cusack
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

10.  Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process.

Authors:  G Burnstock; R Crowe; C Kennedy; J Török
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.